Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Neal DN[au]:

Biomarkers in Diabetic Retinopathy. Jenkins AJ et al. Rev Diabet Stud. (2015)

Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas. Graf A et al. J Diabetes Sci Technol. (2017)

Insulin pumps in general practice. Paldus B et al. Aust Prescr. (2018)

Search results

Items: 1 to 50 of 55

1.

Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study.

Lee MH, Vogrin S, Paldus B, Jones HM, Obeyesekere V, Sims C, Wyatt SA, Ward GM, McAuley SA, MacIsaac RJ, Krishnamurthy B, Sundararajan V, Jenkins AJ, O'Neal DN.

Diabetes Technol Ther. 2019 Jul 2. doi: 10.1089/dia.2019.0120. [Epub ahead of print]

PMID:
31264889
2.

Hypoglycemia in People with Type 2 Diabetes and CKD.

Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE, Furler J, O'Neal DN, Little R, Trence D, Hirsch IB, Bansal N, de Boer IH.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):844-853. doi: 10.2215/CJN.11650918. Epub 2019 Apr 17.

PMID:
30996047
3.

SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission.

Hamblin PS, Wong R, Ekinci EI, Fourlanos S, Shah S, Jones AR, Hare MJL, Calder GL, Epa DS, George EM, Giri R, Kotowicz MA, Kyi M, Lafontaine N, MacIsaac RJ, Nolan BJ, O'Neal DN, Renouf D, Varadarajan S, Wong J, Xu S, Bach LA.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3077-3087. doi: 10.1210/jc.2019-00139.

PMID:
30835263
4.

Empagliflozin as an adjunctive therapy for type 1 diabetes.

MacIsaac RJ, Lee MH, McAuley SA, Ward GM, O'Neal DN.

Ann Transl Med. 2018 Dec;6(Suppl 2):S134. doi: 10.21037/atm.2018.12.52. No abstract available.

5.

Insulin pumps in general practice.

Paldus B, Lee MH, O'Neal DN.

Aust Prescr. 2018 Dec;41(6):186-190. doi: 10.18773/austprescr.2018.056. Epub 2018 Dec 3. Review. No abstract available.

6.

The Clinical Case for the Integration of a Ketone Sensor as Part of a Closed Loop Insulin Pump System.

Lee MH, Paldus B, Krishnamurthy B, McAuley SA, Shah R, Jenkins AJ, O'Neal DN.

J Diabetes Sci Technol. 2019 Jan 10:1932296818822986. doi: 10.1177/1932296818822986. [Epub ahead of print]

PMID:
30628470
7.

Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study.

Paldus B, Lee MH, Jones HM, McAuley SA, Horsburgh JC, Roem KL, Ward GM, MacIsaac RJ, Cohen N, Colman PG, Jenkins AJ, O'Neal DN.

Diabetes Technol Ther. 2019 Jan;21(1):56-58. doi: 10.1089/dia.2018.0279.

PMID:
30620641
8.

Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol.

de Bock M, McAuley SA, Abraham MB, Smith G, Nicholas J, Ambler GR, Cameron FJ, Fairchild JM, King BR, Geelhoed EA, Davis EA, O'Neal DN, Jones TW; Australian JDRF Closed-Loop Research Group.

BMJ Open. 2018 Aug 13;8(8):e020275. doi: 10.1136/bmjopen-2017-020275.

9.

GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.

Furler J, O'Neal DN, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Browne JL, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins AJ, Liew D, Clarke P, Best J.

BMJ Open. 2018 Jul 17;8(7):e021435. doi: 10.1136/bmjopen-2017-021435.

10.

Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial.

Proietto J, Malloy J, Zhuang D, Arya M, Cohen ND, de Looze FJ, Gilfillan C, Griffin P, Hall S, Nathow T, Oldfield GS, O'Neal DN, Roberts A, Stuckey BGA, Yue D, Taylor K, Kim D.

Diabetologia. 2018 Sep;61(9):1918-1922. doi: 10.1007/s00125-018-4677-0. Epub 2018 Jul 11.

PMID:
29992370
11.

Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol.

McAuley SA, de Bock MI, Sundararajan V, Lee MH, Paldus B, Ambler GR, Bach LA, Burt MG, Cameron FJ, Clarke PM, Cohen ND, Colman PG, Davis EA, Fairchild JM, Hendrieckx C, Holmes-Walker DJ, Horsburgh JC, Jenkins AJ, Kaye J, Keech AC, King BR, Kumareswaran K, MacIsaac RJ, McCallum RW, Nicholas JA, Sims C, Speight J, Stranks SN, Trawley S, Ward GM, Vogrin S, Jones TW, O'Neal DN.

BMJ Open. 2018 Jun 9;8(6):e020274. doi: 10.1136/bmjopen-2017-020274.

12.

Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common.

Larsson CR, Januszewski AS, McGrath RT, Ludvigsson J, Keech AC, MacIsaac RJ, Ward GM, O'Neal DN, Fulcher GR, Jenkins AJ.

Intern Med J. 2018 Sep;48(9):1080-1086. doi: 10.1111/imj.13798.

PMID:
29573166
13.

Lipid-lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic.

Kiburg KV, Ward GM, O'Neal DN, MacIsaac RJ.

Intern Med J. 2018 Feb;48(2):201-204. doi: 10.1111/imj.13691.

PMID:
29415350
14.

Predictors of insulin uptake among adults with type 2 diabetes in the Stepping Up Study.

Holmes-Truscott E, Furler J, Blackberry I, O'Neal DN, Speight J.

Diabetes Res Clin Pract. 2017 Nov;133:204-210. doi: 10.1016/j.diabres.2017.01.002. Epub 2017 Jan 23.

PMID:
29122108
15.

Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study.

Jayawardene DC, McAuley SA, Horsburgh JC, Gerche A, Jenkins AJ, Ward GM, MacIsaac RJ, Roberts TJ, Grosman B, Kurtz N, Roy A, O'Neal DN.

Diabetes Technol Ther. 2017 Jun;19(6):340-348. doi: 10.1089/dia.2016.0461. Epub 2017 Jun 2.

PMID:
28574723
16.

"It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes.

Hendrieckx C, Poole LA, Sharifi A, Jayawardene D, Loh MM, Horsburgh JC, Bach LA, Colman PG, Kumareswaran K, Jenkins AJ, MacIsaac RJ, Ward GM, Grosman B, Roy A, O'Neal DN, Speight J.

Diabetes Technol Ther. 2017 Jul;19(7):410-416. doi: 10.1089/dia.2017.0007. Epub 2017 May 24.

PMID:
28537437
17.

Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend.

Graf A, Ward GM, Vogrin S, Sundararajan V, Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Roy A, Jones TW, O'Neal DN.

Diabetes Technol Ther. 2017 Jul;19(7):438-439. doi: 10.1089/dia.2017.0049. Epub 2017 May 24. No abstract available.

PMID:
28537427
18.

Asymmetric changes in circulating insulin levels after an increase compared with a reduction in insulin pump basal rate in people with Type 1 diabetes.

McAuley SA, Ward GM, Horsburgh JC, Gooley JL, Jenkins AJ, MacIsaac RJ, O'Neal DN.

Diabet Med. 2017 Aug;34(8):1158-1164. doi: 10.1111/dme.13371. Epub 2017 May 23.

PMID:
28453877
19.

Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.

Graf A, McAuley SA, Sims C, Ulloa J, Jenkins AJ, Voskanyan G, O'Neal DN.

J Diabetes Sci Technol. 2017 Mar;11(2):308-314. doi: 10.1177/1932296816682762. Epub 2016 Dec 13. Review.

20.

Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.

Sharifi A, De Bock MI, Jayawardene D, Loh MM, Horsburgh JC, Berthold CL, Paramalingam N, Bach LA, Colman PG, Davis EA, Grosman B, Hendrieckx C, Jenkins AJ, Kumareswaran K, Kurtz N, Kyoong A, MacIsaac RJ, Speight J, Trawley S, Ward GM, Roy A, Jones TW, O'Neal DN.

Diabetes Technol Ther. 2016 Dec;18(12):772-783. Epub 2016 Nov 11.

PMID:
27835037
21.

The Big Five Personality Traits and Intimate Partner Violence: Findings From a Large, Nationally Representative Sample.

Ulloa EC, Hammett JF, O'Neal DN, Lydston EE, Leon Aramburo LF.

Violence Vict. 2016 Dec 1;31(6):1100-1115. doi: 10.1891/0886-6708.VV-D-15-00055. Epub 2016 Sep 16.

PMID:
27640426
22.

Factors associated with duration of inpatient hospital stay for patients with diabetes mellitus admitted to a medical unit in a community public hospital.

Lee MH, Liprino L, Brooks J, Cayzer B, Weedon F, Bermingham K, Jenkins AJ, Rowley K, O'Neal DN.

Aust J Prim Health. 2017 Apr;23(1):23-30. doi: 10.1071/PY16036.

PMID:
27465014
23.

Peripheral neuropathy in the hands of people with diabetes mellitus.

Ennis SL, Galea MP, O'Neal DN, Dodson MJ.

Diabetes Res Clin Pract. 2016 Sep;119:23-31. doi: 10.1016/j.diabres.2016.06.010. Epub 2016 Jun 18.

PMID:
27420380
24.

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.

Maahs DM, Buckingham BA, Castle JR, Cinar A, Damiano ER, Dassau E, DeVries JH, Doyle FJ 3rd, Griffen SC, Haidar A, Heinemann L, Hovorka R, Jones TW, Kollman C, Kovatchev B, Levy BL, Nimri R, O'Neal DN, Philip M, Renard E, Russell SJ, Weinzimer SA, Zisser H, Lum JW.

Diabetes Care. 2016 Jul;39(7):1175-9. doi: 10.2337/dc15-2716. Review.

25.

Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors.

Januszewski AS, Sutanto SS, McLennan S, O'Neal DN, Keech AC, Twigg SM, Jenkins AJ.

Diabetes Res Clin Pract. 2016 Jul;117:4-11. doi: 10.1016/j.diabres.2016.04.040. Epub 2016 Apr 27.

PMID:
27329016
26.

Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study.

McAuley SA, Horsburgh JC, Ward GM, La Gerche A, Gooley JL, Jenkins AJ, MacIsaac RJ, O'Neal DN.

Diabetologia. 2016 Aug;59(8):1636-44. doi: 10.1007/s00125-016-3981-9. Epub 2016 May 11.

PMID:
27168135
27.

Feasibility of an Orthogonal Redundant Sensor incorporating Optical plus Redundant Electrochemical Glucose Sensing.

McAuley SA, Dang TT, Horsburgh JC, Bansal A, Ward GM, Aroyan S, Jenkins AJ, MacIsaac RJ, Shah RV, O'Neal DN.

J Diabetes Sci Technol. 2016 May 3;10(3):679-88. doi: 10.1177/1932296816629982. Print 2016 May.

28.

Willingness to initiate insulin among adults with type 2 diabetes in Australian primary care: Results from the Stepping Up Study.

Holmes-Truscott E, Blackberry I, O'Neal DN, Furler JS, Speight J.

Diabetes Res Clin Pract. 2016 Apr;114:126-35. doi: 10.1016/j.diabres.2015.12.011. Epub 2016 Jan 12.

PMID:
26818893
29.

Biomarkers in Diabetic Retinopathy.

Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, O'Neal DN, Januszewski AS.

Rev Diabet Stud. 2015 Spring-Summer;12(1-2):159-95. doi: 10.1900/RDS.2015.12.159. Epub 2015 Aug 10. Review.

30.

Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring.

Sharifi A, Varsavsky A, Ulloa J, Horsburgh JC, McAuley SA, Krishnamurthy B, Jenkins AJ, Colman PG, Ward GM, MacIsaac RJ, Shah R, O'Neal DN.

J Diabetes Sci Technol. 2016 May 3;10(3):669-78. doi: 10.1177/1932296815612096. Print 2016 May.

31.

An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.

Blackberry ID, Furler JS, Ginnivan LE, Manski-Nankervis JA, Jenkins A, Cohen N, Best JD, Young D, Liew D, Ward G, O'Neal DN.

Diabetes Res Clin Pract. 2014 Nov;106(2):247-55. doi: 10.1016/j.diabres.2014.08.011. Epub 2014 Sep 8.

PMID:
25271117
32.

New treatments for type 2 diabetes: cardiovascular protection beyond glucose lowering?

Jayawardene D, Ward GM, O'Neal DN, Theverkalam G, MacIsaac AI, MacIsaac RJ.

Heart Lung Circ. 2014 Nov;23(11):997-1008. doi: 10.1016/j.hlc.2014.05.007. Epub 2014 Jun 10. Review.

PMID:
24996388
33.

An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol.

Blackberry ID, Furler JS, Ginnivan LE, Derraz H, Jenkins A, Cohen N, Best JD, Young D, Liew D, Ward G, Manski-Nankervis JA, O'Neal DN.

BMC Fam Pract. 2014 May 3;15:82. doi: 10.1186/1471-2296-15-82.

34.

Plasma semicarbazide-sensitive amine oxidase activity in type 1 diabetes is related to vascular and renal function but not to glycaemia.

Januszewski AS, Mason N, Karschimkus CS, Rowley KG, Best JD, O'Neal DN, Jenkins AJ.

Diab Vasc Dis Res. 2014 Jul;11(4):262-269. Epub 2014 May 22.

PMID:
24853908
35.

Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set.

O'Neal DN, Adhya S, Jenkins A, Ward G, Welsh JB, Voskanyan G.

J Diabetes Sci Technol. 2013 Mar 1;7(2):381-8.

36.

Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.

Januszewski AS, Sachithanandan N, Karschimkus C, O'Neal DN, Yeung CK, Alkatib N, Jenkins AJ.

Diabet Med. 2012 Jun;29(6):726-33. doi: 10.1111/j.1464-5491.2011.03562.x.

PMID:
22211881
37.

An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life.

Jenkins AJ, Krishnamurthy B, Best JD, Cameron FJ, Colman PG, Hamblin PS, O'Connell MA, Rodda C, Teede H, O'Neal DN.

Diabetes Technol Ther. 2011 Feb;13(2):105-9. doi: 10.1089/dia.2010.0139.

PMID:
21284476
38.

Increased serum kallistatin levels in type 1 diabetes patients with vascular complications.

Jenkins AJ, McBride JD, Januszewski AS, Karschimkus CS, Zhang B, O'Neal DN, Nelson CL, Chung JS, Harper CA, Lyons TJ, Ma JX.

J Angiogenes Res. 2010 Sep 22;2:19. doi: 10.1186/2040-2384-2-19.

39.

Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.

Jenkins AJ, Krishnamurthy B, Best JD, Cameron FJ, Colman PG, Farish S, Hamblin PS, O'Connell MA, Rodda C, Rowley K, Teede H, O'Neal DN.

Diabetes Care. 2010 Jun;33(6):1242-8. doi: 10.2337/dc09-1481. Epub 2010 Mar 9. Erratum in: Diabetes Care. 2010 Aug;33(8):1911.

40.

Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia.

Luke JN, Brown A, O'Neal DN, O'Dea K, Jenkins AJ, Kelaher M, Best JD, Rowley KG.

Med J Aust. 2009 May 18;190(10):552-6.

PMID:
19450200
41.

Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.

O'Connell MA, Donath S, O'Neal DN, Colman PG, Ambler GR, Jones TW, Davis EA, Cameron FJ.

Diabetologia. 2009 Jul;52(7):1250-7. doi: 10.1007/s00125-009-1365-0. Epub 2009 Apr 25.

PMID:
19396424
42.

Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particles.

O'Neal DN, Piers LS, Iser DM, Rowley KG, Jenkins AJ, Best JD, O'Dea K.

Atherosclerosis. 2008 Dec;201(2):368-77. doi: 10.1016/j.atherosclerosis.2008.03.022. Epub 2008 Apr 6.

PMID:
18599067
43.

Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus.

Januszewski AS, Thomas MC, Karschimkus CS, Chung JS, Rowley KG, Nelson CL, O'Neal DN, Dragicevic G, Harper CA, Best JD, Jenkins AJ.

J Med Invest. 2008 Feb;55(1-2):29-36.

44.

Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes.

Jenkins AJ, Zhang SX, Rowley KG, Karschimkus CS, Nelson CL, Chung JS, O'Neal DN, Januszewski AS, Croft KD, Mori TA, Dragicevic G, Harper CA, Best JD, Lyons TJ, Ma JX.

Diabet Med. 2007 Dec;24(12):1345-51. Epub 2007 Oct 29.

PMID:
17971181
45.

Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus.

Davey RA, Tebbutt NC, Favaloro JM, O'neal DN, Rae D, Zajac JD, Best JD.

Lipids Health Dis. 2006 Dec 17;5:29.

46.

Octreotide treatment of severe diabetic diarrhoea.

Meyer C, O'Neal DN, Connell W, Alford F, Ward G, Jenkins AJ.

Intern Med J. 2003 Dec;33(12):617-8. No abstract available.

PMID:
14656240
47.

A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb.

O'Neal DN, Dragicevic G, Rowley KG, Ansari MZ, Balazs N, Jenkins A, Best JD.

Diabetes Care. 2003 Jan;26(1):199-205.

PMID:
12502681
48.

Diabetic dyslipidaemia: current treatment recommendations.

Best JD, O'Neal DN.

Drugs. 2000 May;59(5):1101-11. Review.

PMID:
10852642
49.

Supplemental Content

Loading ...
Support Center